Flu activity in the US is climbing earlier than usual, with the West Coast already seeing the highest levels by early October and the A(H1)pdm09 strain dominating national cases.
Scientists are closely tracking an emerging G155E mutation in some H1N1 viruses that affects an antigenic region of the virus and may alter how antibodies recognise it, although overall activity across the country remains low.
